Close Menu

HIV

The Athens, Ohio-based firm licensed novel yeast-based virus cloning technology that will be used for HIV pharmacogenomics and other disease areas.

News Briefs: Feb 4, 2009

Premium

Cerenis, Montreal Heart Institute, UVA, Ortho Clinical, Mirna, UCSF, Case Western, Diagnostic Hybrids, iBridge Network, Ben Franklin Tech Partners, and more…

Revenues for the company's diagnostics group increased 3 percent. This division includes molecular diagnostics, which posted a 2 percent dip in revenues, and applied sciences, which recorded an 11 percent increase in sales.

A Whole New System

Premium

Now in its ninth year, the experiment that was the Institute for Systems Biology has become an established research organization known for its focus on translational science.

Pages

A South African university has told the Wellcome Sanger Institute to return DNA samples it has from indigenous African communities, The Times reports.

The University of California, Berkeley's Rasmus Nielsen and Xinzhu Wei have retracted their CCR5 gene paper due to a technical artifact.

 

University of Virginia researchers are exploring a genetic risk test to gauge type 1 diabetes risk, NPR reports.

In PNAS this week: researchers compare two high-grade neuroendocrine lung cancers, height among ancient Europeans, and more.